University of Vermont | GenomeWeb

University of Vermont

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

Metagenomic tools are shedding light on how microbes survive in and contribute to environments ranging from wetlands to natural oil seepage sites, according to presentations at this year's ABRF meeting.

In an assessment using standardized RNA samples, sequencing platforms showed both intra-platform reliability and inter-platform agreement, according to findings presented by an Association of Biomedical Resource Facilities working group at the organization's annual meeting last w

Sarkar, who is director of biomedical informatics at the University of Vermont's Center for Clinical and Translational Science, said biomedical informaticians should be involved wherever translational barriers need to be surmounted.

The subsidiary, MetaCytoLytics, will commercialize cancer therapies based on metabolic disruption technology developed at the University of Colorado and the University of Vermont by the same inventor.

Funding Update

Premium

Recent NSF Awards in Proteomics and Protein Research

Genotyping Tech Guide

Premium

Genome Technology Genotyping Tech Guide

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.